Immune ablation and stem cell transplantation for severe Evans syndrome and refractory thrombocytopenic purpura

Bone Marrow Transplantation

Volumn 23, Issue 12, 1999, Pages 1215-1216

  Marmont, M A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; STEROID;

AUTOIMMUNE HEMOLYTIC ANEMIA; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; SHORT SURVEY; SPLENECTOMY; STEM CELL TRANSPLANTATION; THROMBOCYTOPENIC PURPURA;

EID: 0344690141     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701823     Document Type: Short Survey

References (26)

1. Fisher JA. The cryptogenic acquired haemolytic anaemias. Quart J Med 1947; 10: 245-262.
2. Evans RS, Takahashi K, Duane RT et al. Primary thrombocytopenic purpura and acquired haemolytic anaemia. Evidence for a common aetiology. Arch Intern Med 1951; 87: 48-65.
3. Dacie JV. The Haemolytic Anaemias. Vol 3. The Autoimmune Haemolytic Anaemias. Churchill Livingstone: Edinburgh, 1992.
4. Lahita RG (ed). Systemic Lupus Erythematosus. Academic Press: San Diego, 1999.
5. Marmont AM. Perspective: immune ablation with stem cell rescue: a possible cure for systemic lupus erythematosus. Lupus 1993; 2: 151-156.
6. Tyndall A, Gratwohl A. Blood and marrow stem cell transplantation in autoimmune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow transplantation (EBMT). Bone Marrow Transplant 1997; 19: 643-645.
7. Marmont AM. Stem cell transplantation for severe autoimmune diseases: progress and problems. Haematologica 1998; 83: 733-743.
8. Raetz E, Beatty PG, Rose J. Treatment of severe Evans syndrome with an allogeneic cord blood transplant. Bone Marrow Transplant 1997; 20: 427-429.
9. Martino R, Sureda A, Brunet S. Peripheral blood stem cell mobilization in a refractory autoimmune Evans syndrome: a cautionary case report. Bone Marrow Transplant 1997; 20: 521.
10. +) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome. Lupus 1998; 7: 492-494.
11. Brodsky RA, Sensenbrenner LL, Jones RJ. Complete remission in severe aplastic anemia after high dose cyclophosphamide without bone marrow transplantation. Blood 1996; 87: 491-494.
12. Brodsky RA, Petri M, Douglas Smith B et al. Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Ann Intern Med 1998; 12: 1031-1035.
13. Karpaktin S. Autoimmune (idiopathic) thrombocytopenic purpura. Lancet 1997; 349: 1531-1536.
14. McMillan R. Therapy for adults with refractory chronic immune thrombocytopenic purpura. Ann Intern Med 1997; 126: 307-314.
15. Lim SH, Kell J, Al-Sabah A et al. Peripheral blood stem-cell transplantation for refractory autoimmune thrombocytopenic purpura. Lancet 1997; 340: 475 (letter).
16. Skoda RC, Tichelli A, Tyndall A et al. Autologous peripheral blood stem cell transplantation in refractory thrombocytopenic purpura. Br J Haematol 1997; 99: 56-57.
17. Marmont AM, van Lint MT, Occhini D et al. Failure of autologous stem cell transplantation in refractory thrombocytopenic purpura. Bone Marrow Transplant 1998; 22: 227-228.
18. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 1997; 126: 376-380.
19. George JN, Woolf SH, Raskob GE et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88: 3-40.
20. The American Society of Hematology ITP Practice Guideline Panel. Diagnosis and treatment of idiopathic thrombocytopenic purpura: recommendations of the American Society of Hematology. Ann Intern Med 1997; 126: 319-326.
21. Emilia G, Messora C, Longo G, Bertesi M. Long-term salvage treatment in refractory autoimmune haematological disorders. Br J Haematol 1996; 93: 341-344.
22. Cosgriff TM, Black ML, Stein W III. Successful treatment of severe refractory thrombocytopenic purpura with liposomal doxorubicin. Am J Hematol 1998; 57: 85-86.
23. Boitard C. B cells and Autoantibody Production in Autoimmune Diseases. Landes: Singapore, 1996.
24. Van Bekkum DW. New opportunities for the treatment of severe autoimmune diseases: bone marrow transplantation. Clin Immunol Immunopathol 1998; 89: 1-10.
25. Waldmann H, Cobbold S. Reprogramming the immune system. In: Lydyard PM, Brostoff J (eds). Autoimmune disease. Aethiopathogenesis, Diagnosis and Treatment. Blackwell, Oxford, 1994, pp 164-165.
26. Slavin S. Treatment of life threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT. Bone Marrow Transplant 1993; 12: 201-210.